Zhejiang Vacin Biomedicine

Zhejiang Vacin Biomedicine is a China-based biotechnology company dedicated to the research, development, and commercialization of human vaccines. The company focuses on addressing significant public health challenges through its portfolio of prophylactic vaccines, including candidates for rabies, influenza, and pneumococcal infections. Vacin Biomedicine utilizes advanced technology platforms such as Vero cell culture and polysaccharide-protein conjugation to develop high-quality biological products. With large-scale GMP manufacturing facilities located in Huzhou, the company is positioned to supply both domestic and international markets. Its lead programs are currently in late-stage clinical development, moving toward commercialization.